VIM and neoplasm: Immunohistochemistry analysis showed a significant increase in E-Cadherin, and reduction in MMP-2 and Vimentin level in tumor samples obtained from animals simultaneously administered Iminodibenzyl (20 mg/kg) and DGLA (5 mg) (Fig. 6a, P < 0.001).